One single gene changes so much
Every cell carries a blueprint for our body. In Finn, a tiny part of it is changed: the SLC6A1 gene. That is why his brain cannot calm down properly. This leads to seizures and makes learning and speaking hard for him. Here we explain, step by step, what lies behind it.

What SLC6A1 means for Finn
We first noticed tremor episodes in January 2023. Epilepsy was diagnosed in June 2024; before his first medication Finn had more than 200 absence seizures a day. The genetic diagnosis followed in February 2025. Today, at four, Finn lives with these consequences:
- Epilepsy, several seizure types
- Significant developmental delay
- Delayed speech
- Slower information processing
- Sleep problems
- ADHD-like and autistic traits
- Intense meltdowns
- Tremors
- Balance problems, frequent falls
- Low muscle tone, weak posture
- Tires quickly, little stamina
SLC6A1 in five steps
Genes are recipes
Picture every cell in the body as a kitchen with a thick cookbook inside: around 20,000 recipes, the genes. Each recipe describes how the cell builds a particular tool, a protein.
Every recipe exists twice: one from mum, one from dad. In Finn, one of his two SLC6A1 recipes is changed – much like a swapped letter that makes the instructions useless. Usually it happens entirely by chance, as a new change (de novo); nobody did anything wrong.
The brain needs accelerator and brake
Nerve cells constantly send each other messages. Some messengers act like an accelerator (“keep going!”), others like a brake (“calm down now”). The most important braking messenger is called GABA. It is a neurotransmitter – a chemical messenger nerve cells use to signal to each other.
A healthy brain keeps both finely balanced, thousands of times per second. That is what lets it learn, speak, move and settle down.
GAT-1 is the cleaner
A brake must also be released again. After every signal a tiny “vacuum cleaner” in the cell wall pulls the GABA back in: the transporter GAT-1. The SLC6A1 recipe is exactly the blueprint for this cleaner.
Finn has too few cleaners. GABA lingers too long, the brake becomes unreliable – sometimes too strong, sometimes at the wrong moment.
Built – but never delivered
Why are cleaners missing? The cell builds GAT-1 in a kind of factory and then ships it to the cell wall. Because of the change in the recipe, the part is folded wrongly. The cell's quality control notices, holds it back and scraps it.
Only the cleaners from the healthy copy remain – about half, or less. That isn't enough. This is exactly where therapies come in: a folding helper so more parts get through, or a gene therapy that supplies a new, healthy recipe.
When the brain falls into lockstep
Sounds paradoxical: why are there epileptic seizures if there is too much brake? The brain has pacemakers that keep the cortex in rhythm. If too much GABA constantly lingers there, these circuits start to oscillate – and suddenly large parts of the brain “march” in lockstep, about three times per second.
That is an absence seizure: a few seconds in which Finn isn't there. From outside you often only see a blank stare. On an EEG you see the typical spike-wave pattern.
Simplified from Samanta 2026 and Goodspeed 2023.
Rare – but not a one-off
Sources: Carvill 2015, Samanta 2026 (review of 51 studies), López-Rivera 2020. Medical name: SLC6A1-NDD, OMIM 616421.
Three areas that shape everyday life
Seizures
The most common are absence seizures (60–72%): seconds in which the child is “gone”. There are also myoclonic-atonic and atonic seizures, where the body suddenly jerks or goes limp. Many children meet the criteria for Doose syndrome. Seizures usually start between 14 months and 5 years.
Development & speech
Almost all children have developmental delays. Speech is hit hardest, both speaking and understanding. Learning takes a lot of repetition. Augmentative and alternative communication (AAC) with signs or picture cards helps reduce frustration.
Body & behaviour
Low muscle tone (60–71%), tremor and unsteady gait (40–48%), sleep problems and autistic traits (22–65%) are common. How severe the autism is shapes quality of life even more than the seizures do.
Figures based on Samanta (2026) and Goodspeed et al. (2023).
Why time matters
Once the epileptic seizures begin, development often gets worse: in studies, 60% of children had a developmental delay before the first seizure, 84% afterwards. Some children even lose what they could already do – similar to dementia.
The brain's “brakes” form very early. Researchers therefore assume: the earlier a therapy starts, the more it can preserve. That is why time is of the essence for Finn.
Common questions
Is SLC6A1 inherited?
Usually not. In most cases the change arises spontaneously (de novo). Around 17% of known variants were inherited, often with very different severity within one family.
Is there a cure?
Not yet. Medication can ease seizures but does not treat the cause. In September 2025 a child in the USA became the first to receive gene therapy. More on the gene therapy & research page.
What helps Finn today?
Anti-seizure medication – since his stay at the Kork Epilepsy Centre, Finn's seizures have been well controlled. Since September 2026 he has also been taking Ravicti (4-phenylbutyrate) off-label. On top of that come weekly special-needs support and occupational therapy.
Do all patients have the same symptoms?
No. How severe it is depends, among other things, on how much function the transporter still has. Even the same variant can look very different. Milder cases without epilepsy probably often go undiagnosed.
How many families are there in Germany?
About 20 affected families are currently connected through the association SLC6A1 Deutschland e.V. The real number is probably higher. Finn's father David sits on the association's board.
Help us give Finn a chance.
Sources
- Samanta (2026): SLC6A1–Related Neurodevelopmental Disorder: A Scoping Review of Clinical Features and Emerging Therapeutic Strategies
- Goodspeed et al. (2023): SLC6A1-Related Neurodevelopmental Disorder (GeneReviews)
- Carvill et al. (2015): Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures
- López-Rivera et al. (2020): A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants
- Mermer et al. (2021): Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons
- Kalvakuntla et al. (2023): Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder
This page does not replace medical advice. Compiled by Finn's parents, as of October 2026.